Publications

Detailed Information

PRE-OPerative ECHOcardiograhy for prevention of cardiovascular events after non-cardiac surgery in intermediate- and high-risk patients: protocol for a low-interventional, mixed-cohort prospective study design (PREOP-ECHO)

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors

Kim, Eun K.; Choi, Hong-Mi; Choi, Eui-Young; Lee, Hye S.; Park, Goeun; Han, Dong W.; Lee, Sang-Eun; Park, Chan Seok; Hwang, Ji-won; Choi, Jae H.; Kim, Mi-Na; Kim, Hyung-Kwan; Kim, Dae-Hee; Shin, Sung-Hee; Sohn, Il S.; Shin, Mi-Seung; Na, Jin O.; Cho, Iksung; Lee, Sun H.; Park, Yong H.; Park, Tae-Ho; Kim, Kye H.; Cho, Goo-Young; Jung, Hae O.; Park, Dae-Gyun; Hong, Ji Y.; Kang, Duk-Hyun

Issue Date
2022-09-14
Citation
Trials. 2022 Sep 14;23(1):776
Abstract
Abstract

Background
Cardiac evaluation using transthoracic echocardiography before noncardiac surgery is common in real-world practice. However, evidence supporting preoperative echocardiography is lacking. This study aims to evaluate the additional benefit of preoperative echocardiography in predicting postoperative cardiovascular events (CVE) in noncardiac surgery.


Methods
This study is designed as a multicenter, prospective study to assess the utility of preoperative echocardiography in patients undergoing intermediate- or high-risk noncardiac surgery. This trial comprises two studies: (1) a randomized controlled trial (RCT) for patients undergoing intermediate-risk surgery with fewer than three clinical risk factors from the revised cardiac risk index (intermediate-risk group) and (2) a prospective cohort study for patients undergoing intermediate-risk surgery with three or more clinical risk factors, or who undergo high-risk surgery regardless of the number of clinical risk factors (high-risk group). We hypothesize that the use of preoperative echocardiography will reduce postoperative CVEs in patients undergoing intermediate- to high-risk surgery through discovery of and further intervention for unexpected cardiac abnormalities before elective surgery. A total of 2330 and 2184 patients will be enrolled in the two studies. The primary endpoint is a composite of all-cause death; aborted sudden cardiac arrest; type I acute myocardial infarction; clinically diagnosed unstable angina; stress-induced cardiomyopathy; lethal arrhythmia, such as sustained ventricular tachycardia or ventricular fibrillation; and/or newly diagnosed or acutely decompensated heart failure within 30 days after surgery.


Discussion
This study will be the first large-scale prospective study examining the benefit of preoperative echocardiography in predicting postoperative CVE. The PREOP-ECHO trial will help doctors identify patients at risk of postoperative CVE using echocardiography and thereby reduce postoperative CVEs.


Trial registration
The Clinical Research Information Service
KCT0006279

for RCT and
KCT0006280

for prospective cohort study. Registered on June 21, 2021.
URI
https://hdl.handle.net/10371/185088
DOI
https://doi.org/10.1186/s13063-022-06701-2
Files in This Item:
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share